Born and raised in Sydney, Australia, David studied chemistry, immunology and biochemistry at the University of Sydney. He went on to study the deleterious activation of naïve CD8+ T lymphocytes in the liver at the Centenary Institute under the tutelage of Dr Patrick Bertolino. David returned to the University of Sydney for his PhD studies, under the supervision of Professor Richard Payne and Associate Professor Scott Byrne. There, he combined his interests in chemistry and immunology for the development and evaluation of self‑adjuvanting vaccines for cancer and tuberculosis. In the Spiegel lab, David is working towards novel methods to rapidly identify small molecules that target specific proteins and cells. Away from the bench, David enjoys board games, craft beer, and hiking.